Team Gleason getting $6 million in federal funding for ALS patients

  • Oops!
    Something went wrong.
    Please try again later.

BATON ROUGE, La. (BRPROUD) — The Team Gleason Foundation is getting federal funding for $6 million to help ALS patients, according to U.S. Sen. Bill Cassidy (R-LA).

“ALS, or amyotrophic lateral sclerosis, is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord,” according to the ALS Association. The organization said the estimated annual out-of-pocket cost for care for ALS patients is $250,000.

Cassidy said the money will help get specialized equipment, technology and services to over 4,000 people diagnosed with ALS.

“Steve Gleason is a fighter—not just for himself, but for others,” said Cassidy. “Despite facing extreme adversity, he never fails to be a beacon of light. This funding is an example of his tireless work.”

The pioneer of America’s embattled global HIV program recalls the hope after years of despair

According to teamgleason.org, former New Orleans Saints player Gleason was diagnosed with ALS in January 2011. Gleason received the Congressional Gold Medal in 2020.

“When I was diagnosed with the terminal disease, ALS, 13 years ago, there were no treatments for ALS, and that is still largely true today,” said Gleason. “What I found more encouraging was how equipment and technology could help a person survive and thrive while living with the disease. With this knowledge, my wife, Michel, and I founded Team Gleason with the goal of providing critical equipment and technology to those living with ALS, and now we are the leading non-profit provider. This funding is crucial to our ability to meet the needs of the ALS community and my team and I are grateful.”

The money will allow Team Gleason to provide essential care services, including voice and message banking, complex shower and bath chairs and portable power wheelchairs, Cassidy’s office said.

Latest News

For the latest news, weather, sports, and streaming video, head to BRProud.com.